We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Move For Interlocutory Appeal Denied In Reglan Case

Law360 (April 14, 2009, 12:00 AM EDT) -- Generics makers including Teva Pharmaceuticals USA Inc. and Barr Pharmaceuticals LLC have lost their bid for an interlocutory appeal of a ruling denying their motions for summary judgment in a failure-to-warn suit over generic versions of Wyeth Inc.'s heartburn drug Reglan, arguing unsuccessfully that the claims in the suit are preempted by federal law.

Judge William K. Sessions III of the U.S. District Court for the District of Vermont ruled Friday that the U.S. Supreme Court's recent decision in Wyeth v. Levine made clear that drugmakers...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.